The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Nuclear Medicine Group

The nuclear medicine group conducts research on medical imaging systems and detectors, dosimetry in radionuclide therapy and radiation effect on tumours and normal tissues. Our group is collaborating closely with researchers in health care.

Current projects

  • 3D-printed phantoms for quality control of quantitative imaging and dosimetry
  • Simplified methods for analysis of 177Lu-SPECT images acquired for kidney dosimetry
  • Monte Carlo modelling of PET systems in GATE for evaluation of diagnostic procedures
  • Methods for tomographic reconstruction of SPECT images
  • Frameworks of the estimation of uncertainties involved in dosimetric estimates
  • Monte Carlo modelling of CZT-based gamma camera systems in SIMIND and pre-clinical measurements using a hand-held experimental system
  • Activity quantification of 177Lu with 360º-CZT SPECT
  • Connection between absorbed dose and response of neuroendocrine tumours treated with 177Lu-DOTA-TATE
  • Connection between absorbed dose and toxicity of kidneys in treatments with 177Lu-DOTA-TATE

CONTACT

Katarina Sjögreen-Gleisner
 

Visiting address

Dept. of Medical Radiation Physics,
Clinical Sciences, Lund University
Skåne University Hospital, Lund
Barngatan 4, SE-221 85 Lund.

Kampradhuset
8 Jun 2024